Table 1. Literature verification of identified drug resistance-ncRNA relationships.
Drug name | ncRNA | Literature (PMID) |
---|---|---|
5-fluorouracil | hsa-miR-124-3p | 24658854 |
NEAT1 | 28720546 | |
hsa-miR-519d-3p | 29771440 | |
hsa-miR-4728-5p; hsa-miR-6785-5p; hsa-miR-6883-5p; hsa-miR-149-3p | 29061672 | |
Cisplatin | hsa-miR-124-3p | 31298375 |
NEAT1 | 31485599 | |
hsa-miR-1-3p | 29572052 | |
hsa-miR-149-3p | 29731888 | |
hsa-miR-186-3p | 30365062 | |
Gemcitabine | hsa-miR-335 | 31492499 |
hsa-miR-124-3p | 27785603 | |
MALAT1 | 29221115 | |
hsa-miR-320a | 30304549 | |
hsa-miR-24-3p; hsa-miR-30c-5p | 24040438 | |
Imatinib | NEAT1 | 31166382 |
hsa-miR-106b-5p | 28781815 | |
hsa-miR-218-5p | 24706111 | |
hsa-miR-424-5p | 25697481 | |
MALAT1 | 30366670 | |
Docetaxel | NEAT1 | 31672604 |
hsa-miR-106b-5p | 30680612 | |
hsa-miR-218-5p; hsa-miR-29b-3p | 31545228 | |
MALAT1 | 29633510 | |
Doxorubicin | hsa-miR-24-3p | 27681638 |
MALAT1 | 28770558 | |
XIST | 30439718 | |
hsa-miR-148b-3p | 29966970 | |
hsa-miR-455-3p | 30627229 | |
Erlotinib | hsa-miR-124-3p | 30604411 |
hsa-miR-218-5p | 30781783 | |
hsa-miR-30c-5p | 31447008 | |
hsa-miR-30a-5p | 27895663 | |
Tamoxifen | hsa-miR-335-5p | 28008602 |
hsa-miR-92a-3p | 30086458 | |
NEAT1 | 29464864 | |
Paclitaxel | hsa-miR-26b-5p | 30899303 |
hsa-miR-92a-3p | 28209618 | |
hsa-miR-93-5p | 28341962 | |
MALAT1 | 30841025 | |
hsa-miR-92b-3p | 31320936 | |
hsa-miR-766-3p | 31496800 | |
Sorafenib | hsa-miR-335-5p; NEAT1 | 30937906 |
hsa-miR-16-5p | 31341646 | |
hsa-miR-124-3p | 31087496 |